NDC 0113-1720

Nasonex

Mometasone Furoate

Nasonex is a Nasal Spray in the Human Otc Drug category. It is labeled and distributed by L. Perrigo Company. The primary component is Mometasone Furoate.

• Product ID: 0113-1720_13696a8b-366a-4a5e-adea-d5b7bff9e46f
• NDC: 0113-1720
• Product Type: Human Otc Drug
• Proprietary Name: Nasonex
• Generic Name: Mometasone Furoate
• Dosage Form: Spray
• Route of Administration: NASAL
• Marketing Start Date: 2022-06-29
• Marketing Category: NDA /
• Application Number: NDA215712
• Labeler Name: L. Perrigo Company
• Substance Name: MOMETASONE FUROATE
• Active Ingredient Strength: 50 ug/1
• Pharm Classes: Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 0113-1720-01

1 BOTTLE, SPRAY in 1 PACKAGE (0113-1720-01) > 30 SPRAY in 1 BOTTLE, SPRAY

• Marketing Start Date: 2022-06-29
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "Nasonex" or generic name "Mometasone Furoate"

NDC	Brand Name	Generic Name
0085-1288	NASONEX	Mometasone furoate monohydrate
0113-1720	Nasonex	mometasone furoate
50090-0620	NASONEX	NASONEX
0085-1341	ASMANEX	Mometasone Furoate
0085-1461	ASMANEX	Mometasone Furoate
0085-2222	ASMANEX HFA	MOMETASONE FUROATE
0085-4333	ASMANEX HFA	MOMETASONE FUROATE
0085-4334	ASMANEX HFA	MOMETASONE FUROATE
0085-0370	ELOCON	mometasone furoate
0085-0854	ELOCON	Mometasone Furoate
0085-3149	ELOCON	Mometasone Furoate
0168-0270	Mometasone Furoate	mometasone furoate
0168-0271	Mometasone Furoate	mometasone furoate